Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (37) 37
Publication (7) 7
Conference Proceeding (5) 5
Dissertation (5) 5
Book / eBook (3) 3
Newspaper Article (3) 3
Book Chapter (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
animals (12) 12
mice (11) 11
insulin resistance (10) 10
obesity (10) 10
health aspects (9) 9
humans (9) 9
male (9) 9
physiological aspects (8) 8
diabetes (7) 7
gene expression (6) 6
research (6) 6
homeostasis (5) 5
insulin (5) 5
mice, inbred c57bl (5) 5
adipose tissues (4) 4
adult (4) 4
article (4) 4
dendritic cells (4) 4
endocrinology & metabolism (4) 4
female (4) 4
glucose (4) 4
mice, knockout (4) 4
mice, obese (4) 4
obesity - metabolism (4) 4
physiology (4) 4
rodents (4) 4
vitamin a (4) 4
acetylation (3) 3
adipocytes (3) 3
articles (3) 3
cells, cultured (3) 3
diabetes mellitus, type 2 - metabolism (3) 3
glucose - metabolism (3) 3
matrix metalloproteinase 9 - genetics (3) 3
medicine, research & experimental (3) 3
metabolic syndrome (3) 3
middle aged (3) 3
nutrition & dietetics (3) 3
proteins (3) 3
rats (3) 3
type 2 diabetes (3) 3
weight-loss (3) 3
adipose tissue (2) 2
adipose tissue, brown - metabolism (2) 2
adipose tissue, white - metabolism (2) 2
antigen presenting cells (2) 2
bariatric surgery (2) 2
biochemistry & molecular biology (2) 2
bone-marrow (2) 2
care and treatment (2) 2
cell adhesion - drug effects (2) 2
cell biology (2) 2
comparative analysis (2) 2
diabetes mellitus (2) 2
dideoxynucleosides - therapeutic use (2) 2
diet, high-fat (2) 2
diet-induced obesity (2) 2
disease (2) 2
drug therapy (2) 2
extracellular-matrix (2) 2
gelatinase-b (2) 2
gene deletion (2) 2
genetic aspects (2) 2
glucose clamp technique (2) 2
glucose tolerance test (2) 2
histones - metabolism (2) 2
hiv infections - drug therapy (2) 2
hiv-1 - genetics (2) 2
immunology (2) 2
inflammation (2) 2
insulin resistance - physiology (2) 2
insulin sensitivity (2) 2
insulin-resistance (2) 2
lamivudine - therapeutic use (2) 2
lopinavir (2) 2
matrix metalloproteinase 9 - metabolism (2) 2
metabolism (2) 2
molecular sequence data (2) 2
mouse (2) 2
multidisciplinary sciences (2) 2
obesity - genetics (2) 2
obesity - pathology (2) 2
observations (2) 2
p300-cbp transcription factors - metabolism (2) 2
pathway (2) 2
patients (2) 2
phosphorylation (2) 2
ppar-gamma (2) 2
properties (2) 2
public health (2) 2
pyrimidinones - therapeutic use (2) 2
receptors (2) 2
receptors, retinoic acid - antagonists & inhibitors (2) 2
resistance (2) 2
retinoic acid receptor alpha (2) 2
ritonavir - therapeutic use (2) 2
sensitivity (2) 2
society-usa panel (2) 2
t-lymphocytes, regulatory - immunology (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Regulation of metabolism by the innate immune system
by Lackey, Denise E and Olefsky, Jerrold M
Nature Reviews Endocrinology, ISSN 1759-5029, 01/2016, Volume 12, Issue 1, pp. 15 - 20
Low-grade tissue inflammation induced by obesity can result in insulin resistance, which in turn is a key cause of type 2 diabetes mellitus. Cells of the... 
ALTERNATIVELY ACTIVATED MACROPHAGES | ISLET-ASSOCIATED MACROPHAGES | ADIPOSE-TISSUE MACROPHAGES | ENDOCRINOLOGY & METABOLISM | KILLER T-CELLS | NECROSIS-FACTOR-ALPHA | FACTOR-KAPPA-B | ENDOPLASMIC-RETICULUM STRESS | DIET-INDUCED OBESITY | TYPE-2 DIABETES-MELLITUS | INDUCED INSULIN-RESISTANCE | Obesity - immunology | Humans | Inflammation - immunology | Adipose Tissue - immunology | Diabetes Mellitus, Type 2 - metabolism | Obesity - metabolism | Adipose Tissue - metabolism | Inflammation - metabolism | Animals | Immunity, Innate - physiology | Insulin Resistance - physiology | Diabetes Mellitus, Type 2 - immunology | Energy Metabolism - physiology | Adipose tissues | Cytokines | Physiological aspects | Insulin resistance | Genetic aspects | Research | Health aspects | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance
by Fang, Sungsoon and Suh, Jae Myoung and Reilly, Shannon M and Yu, Elizabeth and Osborn, Olivia and Lackey, Denise and Yoshihara, Eiji and Perino, Alessia and Jacinto, Sandra and Lukasheva, Yelizaveta and Atkins, Annette R and Khvat, Alexander and Schnabl, Bernd and Yu, Ruth T and Brenner, David A and Coulter, Sally and Liddle, Christopher and Schoonjans, Kristina and Olefsky, Jerrold M and Saltiel, Alan R and Downes, Michael and Evans, Ronald M
Nature Medicine, ISSN 1078-8956, 2015, Volume 21, Issue 2, pp. 159 - 165
The systemic expression of the bile acid (BA) sensor farnesoid X receptor (FXR) has led to promising new therapies targeting cholesterol metabolism,... 
MEDICINE, RESEARCH & EXPERIMENTAL | HOMEOSTASIS | ACTIVATION | CHOLESTEROL | PGC-1-ALPHA | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOUSE-LIVER | BILE-ACID RECEPTOR | IDENTIFICATION | NUCLEAR RECEPTOR | CELL BIOLOGY | FEEDBACK-REGULATION | FARNESOID-X-RECEPTOR | Insulin Resistance | Adipose Tissue, White - metabolism | Bile Acids and Salts - metabolism | Intestines - metabolism | Receptors, Cytoplasmic and Nuclear - agonists | Fibroblast Growth Factors - drug effects | Obesity - metabolism | Fibroblast Growth Factors - metabolism | Animals | Weight Gain - drug effects | Adipose Tissue, Brown - drug effects | Adipose Tissue, Brown - metabolism | Mice | Glucose Clamp Technique | Adipose Tissue, White - drug effects | Benzene Derivatives - pharmacology | Receptors, Cytoplasmic and Nuclear - metabolism | Adipose tissues | Prevention | Obesity | Transcription factors | Physiological aspects | Insulin resistance | Properties | Tissue engineering | Metabolic disorders | Gastroenterology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Adipocyte PU.1 knockout promotes insulin sensitivity in HFD-fed obese mice
by Lackey, DE and Reis, FCG and Isaac, R and Zapata, RC and El Ouarrat, D and Lee, YS and Bandyopadhyay, G and Ofrecio, JM and Oh, D and Osborn, O
SCIENTIFIC REPORTS, ISSN 2045-2322, 10/2019, Volume 9, Issue 1, pp. 1 - 10
Insulin resistance is a key feature of obesity and type 2 diabetes. PU.1 is a master transcription factor predominantly expressed in macrophages but after HFD... 
STEM-CELLS | ACTIVATED RECEPTOR-GAMMA | PHOSPHORYLATION | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | INHIBIT ADIPOGENESIS | RESISTANCE | PPAR-GAMMA | ALPHA | EXPRESSION | ADIPOSE-TISSUE | Obesity | Phosphorylation | Adipose tissue | Serine | Diabetes mellitus | Homeostasis | Adipocytes | Glucose | Gene expression | Gene deletion | Macrophages | Insulin | Adiponectin | Glucose tolerance | PU.1 protein | Clonal deletion | Insulin resistance | Peroxisome proliferator-activated receptors | Diabetes mellitus (non-insulin dependent)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice
by Oh, Da Young and Walenta, Evelyn and Akiyama, Taro E and Lagakos, William S and Lackey, Denise and Lackey, Denise and Pessentheiner, Ariane R and Sasik, Roman and Hah, Nasun and Chi, Tyler J and Cox, Jason M and Powels, Mary Ann and Di Salvo, Jerry and Sinz, Christopher and Sinz, Christopher and Watkins, Steven M and Armando, Aaron M and Chung, Heekyung and Evans, Ronald M and Quehenberger, Oswald and McNelis, Joanne and Bogner-Strauss, Juliane G and Olefsky, Jerrold M
Nature Medicine, ISSN 1078-8956, 2014, Volume 20, Issue 8, pp. 942 - 947
It is well known that the omega-3 fatty acids (omega-3-FAs; also known as n-3 fatty acids) can exert potent anti-inflammatory effects(1-4). Commonly consumed... 
MEDICINE, RESEARCH & EXPERIMENTAL | CELLS | POTENT | GPR120 | BIOCHEMISTRY & MOLECULAR BIOLOGY | DISEASE | POLYUNSATURATED FATTY-ACIDS | SECRETION | GPR40 | RECEPTORS | CELL BIOLOGY | Nitric Oxide Synthase Type II - biosynthesis | Receptors, G-Protein-Coupled - metabolism | Diabetes Mellitus, Type 2 - genetics | Molecular Sequence Data | Arginase - biosynthesis | Male | Hyperinsulinism - drug therapy | Receptors, G-Protein-Coupled - agonists | Obesity - genetics | T-Lymphocytes, Regulatory - immunology | Insulin Resistance - physiology | Base Sequence | Macrophages - immunology | Fatty Acids, Omega-3 - metabolism | Mice, Inbred C57BL | Inflammation | B-Lymphocytes, Regulatory - immunology | Fatty Liver - drug therapy | Mice, Knockout | Docosahexaenoic Acids - pharmacology | Animals | Mice, Obese | Mice | Receptors, G-Protein-Coupled - genetics | Diabetes Mellitus, Type 2 - drug therapy | Physiological aspects | Insulin resistance | Triglycerides | B cells | Health aspects | Omega-3 fatty acids | Obesity | Fatty acids | Rodents | Inflammatory diseases | Chronic illnesses
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Regulation of adipose branched-chain amino acid catabolism enzyme expression and cross-adipose amino acid flux in human obesity
by Lackey, Denise E and Lynch, Christopher J and Olson, Kristine C and Mostaedi, Rouzbeh and Ali, Mohamed and Smith, William H and Karpe, Fredrik and Humphreys, Sandy and Bedinger, Daniel H and Dunn, Tamara N and Thomas, Anthony P and Oort, Pieter J and Kieffer, Dorothy A and Amin, Rajesh and Bettaieb, Ahmed and Haj, Fawaz G and Permana, Paska and Anthony, Tracy G and Adams, Sean H
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 06/2013, Volume 304, Issue 11, pp. E1175 - E1187
Elevated blood branched-chain amino acids (BCAA) are often associated with insulin resistance and type 2 diabetes, which might result from a reduced cellular... 
Hyperinsulinemia | Diabetes | Bariatric | Protein | Mammalian target of rapamycin | PHYSIOLOGY | ADIPOCYTES | RAT | hyperinsulinemia | PHOSPHORYLATION | bariatric | SENSITIVITY | DEHYDROGENASE | mammalian target of rapamycin | PLASMA | METABOLISM | INSULIN-RESISTANCE | protein | ENDOCRINOLOGY & METABOLISM | TISSUE BLOOD-FLOW | LEUCINE | diabetes | Amino Acids, Branched-Chain - metabolism | Humans | Middle Aged | Adipose Tissue, White - metabolism | Rats | Diabetes Mellitus, Type 2 - metabolism | Insulin - blood | Obesity - metabolism | Rats, Zucker | Animals | Adipocytes - metabolism | Adult | Female | Mice, Obese | Mice | 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) - metabolism | Obesity | Glucose metabolism | Branched chain amino acids | Physiological aspects | Metabolic diseases | Insulin resistance | Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Salmon 2100
: the future of wild Pacific salmon
by Lackey, Robert T and Lach, D. (Denise) and Duncan, Sally
2006, ISBN 9781888569780, xxii, 629
Fishery policy | Pacific salmon | Conservation
Book
Details down arrow
7. Full Text Glucagon regulates gluconeogenesis through KAT2B- and WDR5-mediated epigenetic effects
by Ravnskjaer, Kim and Hogan, Meghan F and Lackey, Denise and Tora, Laszlo and Dent, Sharon Y. R and Olefsky, Jerrold and Montminy, Marc
Journal of Clinical Investigation, ISSN 0021-9738, 10/2013, Volume 123, Issue 10, pp. 4318 - 4328
Circulating pancreatic glucagon is increased during fasting and maintains glucose balance by stimulating hepatic gluconeogenesis. Glucagon triggering of the... 
ENERGY-BALANCE | MEDICINE, RESEARCH & EXPERIMENTAL | ACETYLASE COMPLEX | TARGET GENES | SMALL-MOLECULE MODULATORS | LIVER | TRANSCRIPTION | CREB COACTIVATOR TORC2 | BINDING PROTEIN | INSULIN SENSITIVITY | HEPATIC GLUCOSE-PRODUCTION | Liver - enzymology | p300-CBP Transcription Factors - antagonists & inhibitors | Epigenesis, Genetic | Humans | Molecular Sequence Data | Male | Hepatocytes - metabolism | HEK293 Cells | Conserved Sequence | Acetylation | Amino Acid Sequence | Mice, Inbred C57BL | Cells, Cultured | Glucagon - physiology | Insulin Resistance | Hypoglycemic Agents - pharmacology | Mice, Knockout | p300-CBP Transcription Factors - metabolism | Animals | Gluconeogenesis - genetics | Proteins - metabolism | Glucose - metabolism | Mice, Obese | Mice | Protein Processing, Post-Translational | Histones - metabolism | Methylation | Anacardic Acids - pharmacology | Care and treatment | Transferases | Genetic aspects | Diabetes | Gene expression | Observations | Properties | Insulin resistance | Glucose | Kinases | Insulin | Rodents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer
by Suh, Jae Myoung and Jonker, Johan W and Ahmadian, Maryam and Goetz, Regina and Lackey, Denise and Osborn, Olivia and Huang, Zhifeng and Liu, Weilin and Yoshihara, Eiji and van Dijk, Theo H and Havinga, Rick and Fan, Weiwei and Yin, Yun-Qiang and Yu, Ruth T and Liddle, Christopher and Atkins, Annette R and Olefsky, Jerrold M and Mohammadi, Moosa and Downes, Michael and Evans, Ronald M
Nature, ISSN 0028-0836, 09/2014, Volume 513, Issue 7518, pp. 436 - 439
Fibroblast growth factor 1 (FGF1) is an autocrine/paracrine regulator whose binding to heparan sulphate proteoglycans effectively precludes its circulation.... 
PPAR-GAMMA-FGF1 AXIS | HOMEOSTASIS | METABOLISM | FIBROBLAST | RATS | PPAR-GAMMA | MICE | SUPPRESSION | GROWTH-FACTOR-I | MULTIDISCIPLINARY SCIENCES | Diabetes Mellitus, Experimental - drug therapy | Mitogens - pharmacology | Humans | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Body Weight - drug effects | Male | Muscle, Skeletal - metabolism | Diabetes Mellitus, Type 2 - metabolism | Dose-Response Relationship, Drug | Liver - drug effects | Diet, High-Fat | Muscle, Skeletal - drug effects | Diabetes Mellitus, Experimental - metabolism | Glucose Tolerance Test | Liver - metabolism | Mice, Inbred C57BL | Fibroblast Growth Factor 1 - adverse effects | Insulin Resistance | Insulin - metabolism | Animals | Fibroblast Growth Factor 1 - pharmacology | Glucose - metabolism | Mice, Obese | Mice | Blood Glucose - metabolism | Fibroblast Growth Factor 1 - administration & dosage | Type 2 diabetes | Insulin resistance | Usage | Care and treatment | Fibroblast growth factors | Health aspects | Glucose | Diabetes | Insulin | Rodents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Contributions of adipose tissue architectural and tensile properties toward defining healthy and unhealthy obesity
by Lackey, Denise E and Burk, David H and Ali, Mohamed R and Mostaedi, Rouzbeh and Smith, William H and Park, Jiyoung and Scherer, Philipp E and Seay, Shundra A and McCoin, Colin S and Bonaldo, Paolo and Adams, Sean H
American Journal of Physiology - Endocrinology and Metabolism, ISSN 0193-1849, 02/2014, Volume 306, Issue 3, pp. E233 - E246
The extracellular matrix (ECM) plays an important role in the maintenance of white adipose tissue (WAT) architecture and function, and proper ECM remodeling is... 
Adipose inflammation | Extracellular matrix | Matrix metalloproteinase | Type 2 diabetes mellitus | Bariatric surgery | METABOLIC SYNDROME | PHYSIOLOGY | bariatric surgery | COLLAGEN VI | NUTRITIONALLY INDUCED OBESITY | WEIGHT-LOSS | adipose inflammation | DIET-INDUCED OBESITY | CATHEPSIN-S | MACROPHAGE ACTIVATION | INSULIN-RESISTANCE | ENDOCRINOLOGY & METABOLISM | type 2 diabetes mellitus | matrix metalloproteinase | EXTRACELLULAR-MATRIX | MICE | extracellular matrix | Tensile Strength | Humans | Middle Aged | Collagen Type VI - metabolism | Extracellular Matrix - metabolism | Male | Obesity - physiopathology | Obesity - genetics | Mice, Knockout | Obesity - pathology | Collagen Type VI - genetics | Young Adult | Animals | Adipose Tissue, White - ultrastructure | Adult | Female | Mice | Health Status | Adipose tissues | Biomechanics | Obesity | Physiological aspects | Physiological research | Research | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text TAZ Is a Negative Regulator of PPARγ Activity in Adipocytes and TAZ Deletion Improves Insulin Sensitivity and Glucose Tolerance
by El Ouarrat, Dalila and Isaac, Roi and Lee, Yun Sok and Oh, Da Young and Wollam, Joshua and Lackey, Denise and Riopel, Matthew and Bandyopadhyay, Gautam and Seo, Jong Bae and Sampath-Kumar, Revathy and Olefsky, Jerrold M
Cell Metabolism, ISSN 1550-4131, 11/2019
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment
by Smith, Kimberly Y and Patel, Parul and Fine, Derek and Bellos, Nicholaos and Sloan, Louis and Lackey, Philip and Kumar, Princy N and Sutherland-Phillips, Denise H and Vavro, Cindy and Yau, Linda and Wannamaker, Paul and Shaefer, Mark S and HEAT Study Team
AIDS, ISSN 0269-9370, 07/2009, Volume 23, Issue 12, pp. 1547 - 1556
Background: Abacavir sulfate/lamivudine (ABC/3TC) and tenofovir DF/emtricitabine (TDF/FTC) are widely used nucleoside reverse transcriptase inhibitors for... 
Emtricitabine | Tenofovir | Ritonavir | Lopinavir | Abacavir | Lamivudine | Antiretroviral therapy | emtricitabine | INFECTIOUS DISEASES | MYOCARDIAL-INFARCTION | tenofovir | antiretroviral therapy | NAIVE HIV-1-INFECTED PATIENTS | IMMUNOLOGY | REVERSE-TRANSCRIPTASE INHIBITORS | VIROLOGY | lopinavir | ritonavir | RENAL-FAILURE | abacavir | SOCIETY-USA PANEL | INFECTED PATIENTS | 2008 RECOMMENDATIONS | FANCONI-SYNDROME | lamivudine | Humans | Antiretroviral Therapy, Highly Active - adverse effects | Male | RNA, Viral - blood | Lamivudine - adverse effects | HIV Infections - immunology | Deoxycytidine - therapeutic use | Adenine - adverse effects | Ritonavir - adverse effects | Adenine - therapeutic use | HIV-1 - isolation & purification | Lamivudine - therapeutic use | Ritonavir - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Dideoxynucleosides - adverse effects | Dideoxynucleosides - therapeutic use | Antiretroviral Therapy, Highly Active - methods | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | Anti-HIV Agents - adverse effects | HIV Infections - virology | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Organophosphonates - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | HIV-1 - genetics | HIV Infections - drug therapy | Cardiovascular Diseases - chemically induced | Deoxycytidine - analogs & derivatives | Index Medicus | AIDS/HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Prevalence of Undiagnosed and Inadequately Treated Type 2 Diabetes Mellitus, Hypertension, and Dyslipidemia in Morbidly Obese Patients Who Present for Bariatric Surgery
by Mostaedi, Rouzbeh and Lackey, Denise E and Adams, Sean H and Dada, Stephen A and Hoda, Zahid A and Ali, Mohamed R
Obesity Surgery, ISSN 0960-8923, 6/2014, Volume 24, Issue 6, pp. 927 - 935
Pharmacotherapy is considered the primary treatment modality for diabetes mellitus (DM), hypertension (HTN), and dyslipidemia (DYS). We sought to investigate... 
Hypertension | Obesity | Medicine & Public Health | Comorbidities | Surgery | Diabetes mellitus | Dyslipidemia | Bariatric surgery | Pharmacotherapy | Metabolic syndrome | UNITED-STATES | SURGERY | EUROPEAN-ASSOCIATION | GLYCEMIC CONTROL | RISK-FACTORS | WEIGHT-LOSS | BLOOD-PRESSURE | LIFE-STYLE | DISEASE | CONSENSUS STATEMENT | Bariatric Surgery | Prevalence | Prospective Studies | Obesity, Morbid - surgery | Humans | Middle Aged | Male | Metabolic Syndrome - therapy | Diabetes Mellitus, Type 2 - epidemiology | Obesity, Morbid - complications | Diabetes Mellitus, Type 2 - diagnosis | Dyslipidemias - epidemiology | Metabolic Syndrome - diagnosis | Diabetes Mellitus, Type 2 - therapy | Dyslipidemias - therapy | Adult | Female | Hypertension - epidemiology | Hypertension - therapy | Hypertension - diagnosis | Dyslipidemias - diagnosis | Metabolic Syndrome - epidemiology | Type 2 diabetes | Prevalence studies (Epidemiology) | Comorbidity | Lipids | Gastrointestinal surgery | Diabetes | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial
by Eron, Joseph and Yeni, Patrick and Gathe, Joseph and Estrada, Vicente and DeJesus, Edwin and Staszewski, Schlomo and Lackey, Philip and Katlama, Christine and Young, Benjamin and Yau, Linda and Sutherland-Phillips, Denise and Wannamaker, Paul and Vavro, Cindy and Patel, Lisa and Yeo, Jane and Shaefer, Mark and KLEAN study team
The Lancet, ISSN 0140-6736, 2006, Volume 368, Issue 9534, pp. 476 - 482
Lopinavir-ritonavir is a preferred protease inhibitor co-formulation for initial HIV-1 treatment. Fosamprenavir-ritonavir has shown similar efficacy and safety... 
MEDICINE, GENERAL & INTERNAL | THERAPY | NAIVE PATIENTS | RECOMMENDATIONS | EFAVIRENZ | TENOFOVIR DF | RESISTANCE | AIDS | SOCIETY-USA PANEL | LOPINAVIR/RITONAVIR | NELFINAVIR | Dideoxynucleosides - administration & dosage | Organophosphates - administration & dosage | Lamivudine - administration & dosage | Ritonavir - administration & dosage | HIV-1 - drug effects | Humans | Lopinavir | Pyrimidinones - therapeutic use | Organophosphates - therapeutic use | Carbamates - administration & dosage | HIV Protease Inhibitors - administration & dosage | HIV-1 - genetics | Reverse Transcriptase Inhibitors - administration & dosage | HIV Protease Inhibitors - therapeutic use | Sulfonamides - therapeutic use | Lamivudine - therapeutic use | Ritonavir - therapeutic use | HIV Infections - drug therapy | Dideoxynucleosides - therapeutic use | Pyrimidinones - administration & dosage | Reverse Transcriptase Inhibitors - therapeutic use | Carbamates - therapeutic use | Drug Therapy, Combination | Sulfonamides - administration & dosage | Dosage and administration | Protease inhibitors | Comparative analysis | Drug therapy | HIV infection | Antiviral agents | Research | Drug therapy, Combination | Health aspects | Anti-HIV agents | Antiretroviral drugs | Human immunodeficiency virus--HIV | Samples | Clinical trials | Comparative studies | Clinical medicine | Disease control
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights